Gregg LP[au] - Search Results

Year	Number of Results
2012	1
2017	2
2018	2
2019	3
2020	5
2021	12
2022	10

1

Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment.

Gregg LP, Bossola M, Ostrosky-Frid M, Hedayati SS. Gregg LP, et al. Clin J Am Soc Nephrol. 2021 Sep;16(9):1445-1455. doi: 10.2215/CJN.19891220. Epub 2021 Apr 15. Clin J Am Soc Nephrol. 2021. PMID: 33858827 Free PMC article. Review.

2

Are All SGLT2 Inhibitors Created Equal?

Gregg LP, Navaneethan SD. Gregg LP, et al. Clin J Am Soc Nephrol. 2021 Sep;16(9):1309-1311. doi: 10.2215/CJN.09720721. Clin J Am Soc Nephrol. 2021. PMID: 34497107 Free PMC article. No abstract available.

3

Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?

Gregg LP, Hedayati SS. Gregg LP, et al. Am J Kidney Dis. 2018 Nov;72(5):728-744. doi: 10.1053/j.ajkd.2017.12.007. Epub 2018 Feb 23. Am J Kidney Dis. 2018. PMID: 29478869 Free PMC article. Review.

4

Considerations in the Study of Body Mass Index Variability.

Gregg LP, Navaneethan SD. Gregg LP, et al. J Am Soc Nephrol. 2021 Oct;32(10):2395-2397. doi: 10.1681/ASN.2021060844. J Am Soc Nephrol. 2021. PMID: 34599033 Free PMC article. No abstract available.

5

Early eGFR decline after SGLT2i initiation: knowns and unknowns.

Gregg LP, Navaneethan SD. Gregg LP, et al. Kidney Int. 2021 Mar;99(3):548-550. doi: 10.1016/j.kint.2020.11.021. Kidney Int. 2021. PMID: 33637202

6

Revisiting diuretic choice in chronic kidney disease.

Ali S, Navaneethan SD, Virani SS, Gregg LP. Ali S, et al. Among authors: gregg lp. Curr Opin Nephrol Hypertens. 2022 Sep 1;31(5):406-413. doi: 10.1097/MNH.0000000000000814. Epub 2022 Jul 11. Curr Opin Nephrol Hypertens. 2022. PMID: 35894274 Review.

7

Diagnosis and Management of Depression in Patients With Kidney Disease.

Gregg LP, Trombello JM, McAdams M, Hedayati SS. Gregg LP, et al. Semin Nephrol. 2021 Nov;41(6):505-515. doi: 10.1016/j.semnephrol.2021.10.003. Semin Nephrol. 2021. PMID: 34973695

8

Pharmacologic and psychological interventions for depression treatment in patients with kidney disease.

Gregg LP, Hedayati SS. Gregg LP, et al. Curr Opin Nephrol Hypertens. 2020 Sep;29(5):457-464. doi: 10.1097/MNH.0000000000000629. Curr Opin Nephrol Hypertens. 2020. PMID: 32701597 Free PMC article. Review.

9

Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease.

Triozzi JL, Richardson PA, Gregg LP, Navaneethan SD. Triozzi JL, et al. Among authors: gregg lp. Nephrol Dial Transplant. 2021 Jul 23;36(8):1546-1548. doi: 10.1093/ndt/gfab046. Nephrol Dial Transplant. 2021. PMID: 33599279 Free PMC article. No abstract available.

10

Inflammation and Response to Sertraline Treatment in Patients With CKD and Major Depression.

Gregg LP, Carmody T, Le D, Toto RD, Trivedi MH, Hedayati SS. Gregg LP, et al. Am J Kidney Dis. 2020 Mar;75(3):457-460. doi: 10.1053/j.ajkd.2019.09.007. Epub 2019 Dec 19. Am J Kidney Dis. 2020. PMID: 31866226 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results